Key benefits A once-weekly dual GLP-1 + GIP injection designed to support appetite control, steadier portions, and a weight loss routine that feels easier to stay with when paired with provider guidance
However, we did not find a dose-dependent change in average drinks or AUDIT scores in the medication groups, although a visual downward trend could be observed in the Tirzepatide group
Thats where Semaglutide injections come in
They also show whether GLP-1 could support your appetite regulation and energy balance
Effect of Additional Oral Semaglutide vs Sitagliptin on Glycated Hemoglobin in Adults With Type 2 Diabetes Uncontrolled With Metformin Alone or With Sulfonylurea: The PIONEER 3 Randomized Clinical Trial
Some rare but serious risks with Wegovy include pancreatitis, gallbladder problems, and increased risk of diabetic retinopathy